Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ozer

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Archives of Internal Medicine|September 1, 1986
Primary chemotherapy for localized non-Hodgkin's lymphomas with diffuse histologic characteristics. Preliminary report of a prospective studyG A Gomez, S Reddy, R M Krishnamsetty, et al.
Journal of the National Cancer Institute|November 15, 1989
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology ProgramA D Kaluzny, T Ricketts, R Warnecke, et al.
The New England Journal of Medicine|February 2, 1984
Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemiaT Han, H Ozer, N Sadamori, et al.
The New England Journal of Medicine|February 6, 1997
Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancerM Fanucchi, J Glaspy, J Crawford, et al.
Developments in Biological Standardization|October 17, 1998
SV40 as an oncogenic virus and possible human pathogenR Weiss, A Giordano, P Furth, et al.
The New England Journal of Medicine|July 18, 1991
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancerJ Crawford, H Ozer, R Stoller, et al.
Journal of Biological Response Modifiers|January 1, 1983
Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignanciesH Ozer, M Gavigan, J O'Malley, et al.
Journal of Cellular Biochemistry|January 1, 1994
A 17S multiprotein form of murine cell DNA polymerase mediates polyomavirus DNA replication in vitroY Wu, R Hickey, K Lawlor, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Archives of Internal Medicine|September 1, 1986
Primary chemotherapy for localized non-Hodgkin's lymphomas with diffuse histologic characteristics. Preliminary report of a prospective studyG A Gomez, S Reddy, R M Krishnamsetty, et al.
Journal of the National Cancer Institute|November 15, 1989
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology ProgramA D Kaluzny, T Ricketts, R Warnecke, et al.
The New England Journal of Medicine|February 2, 1984
Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemiaT Han, H Ozer, N Sadamori, et al.
The New England Journal of Medicine|February 6, 1997
Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancerM Fanucchi, J Glaspy, J Crawford, et al.
Developments in Biological Standardization|October 17, 1998
SV40 as an oncogenic virus and possible human pathogenR Weiss, A Giordano, P Furth, et al.
The New England Journal of Medicine|July 18, 1991
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancerJ Crawford, H Ozer, R Stoller, et al.
Journal of Biological Response Modifiers|January 1, 1983
Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignanciesH Ozer, M Gavigan, J O'Malley, et al.
Journal of Cellular Biochemistry|January 1, 1994
A 17S multiprotein form of murine cell DNA polymerase mediates polyomavirus DNA replication in vitroY Wu, R Hickey, K Lawlor, et al.
Pageof 22